Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Temple

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|October 28, 2020
Farewell to our Wonderful Friend and Colleague, J. Richard (Dick) Crout (1929-2020)Robert J Temple, Robert T O'Neill, Carl C Peck
JAMA|April 10, 2014
The imperative of overcoming barriers to the conduct of large, simple trialsZubin J Eapen, Michael S Lauer, Robert J Temple
Circulation|June 15, 2011
Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspectiveKaren A Hicks, Norman L Stockbridge, Shari L Targum, et al.
The New England Journal of Medicine|June 10, 2011
New FDA regulation to improve safety reporting in clinical trialsRachel Behrman Sherman, Janet Woodcock, Janet Norden, et al.
JAMA Network Open|November 1, 2022
Use of US Food and Drug Administration Expedited Drug Development and Review Programs by Orphan and Nonorphan Novel Drugs Approved From 2008 to 2021Andrea N Monge, Daniel W Sigelman, Robert J Temple, et al.
BMJ (Clinical Research Ed.)|August 27, 2020
Two metres or one: what is the evidence for physical distancing in covid-19?Nicholas R Jones, Zeshan U Qureshi, Robert J Temple, et al.
The Journal of Clinical Psychiatry|May 12, 2017
The US Food and Drug Administration's Perspective on the New Antipsychotic PimavanserinMitchell V Mathis, Brendan M Muoio, Paul Andreason, et al.
The Journal of Clinical Psychiatry|September 4, 2015
Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trialsPhillip D Kronstein, Eiji Ishida, Ni A Khin, et al.
The Journal of Clinical Psychiatry|July 28, 2015
Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trialsNi A Khin, Phillip D Kronstein, Peiling Yang, et al.
Journal of the American College of Cardiology|May 5, 2018
Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular DrugsPamela E Scott, Ellis F Unger, Marjorie R Jenkins, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|October 28, 2020
Farewell to our Wonderful Friend and Colleague, J. Richard (Dick) Crout (1929-2020)Robert J Temple, Robert T O'Neill, Carl C Peck
JAMA|April 10, 2014
The imperative of overcoming barriers to the conduct of large, simple trialsZubin J Eapen, Michael S Lauer, Robert J Temple
Circulation|June 15, 2011
Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspectiveKaren A Hicks, Norman L Stockbridge, Shari L Targum, et al.
The New England Journal of Medicine|June 10, 2011
New FDA regulation to improve safety reporting in clinical trialsRachel Behrman Sherman, Janet Woodcock, Janet Norden, et al.
JAMA Network Open|November 1, 2022
Use of US Food and Drug Administration Expedited Drug Development and Review Programs by Orphan and Nonorphan Novel Drugs Approved From 2008 to 2021Andrea N Monge, Daniel W Sigelman, Robert J Temple, et al.
BMJ (Clinical Research Ed.)|August 27, 2020
Two metres or one: what is the evidence for physical distancing in covid-19?Nicholas R Jones, Zeshan U Qureshi, Robert J Temple, et al.
The Journal of Clinical Psychiatry|May 12, 2017
The US Food and Drug Administration's Perspective on the New Antipsychotic PimavanserinMitchell V Mathis, Brendan M Muoio, Paul Andreason, et al.
The Journal of Clinical Psychiatry|September 4, 2015
Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trialsPhillip D Kronstein, Eiji Ishida, Ni A Khin, et al.
The Journal of Clinical Psychiatry|July 28, 2015
Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trialsNi A Khin, Phillip D Kronstein, Peiling Yang, et al.
Journal of the American College of Cardiology|May 5, 2018
Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular DrugsPamela E Scott, Ellis F Unger, Marjorie R Jenkins, et al.
Pageof 3